Oncological risk mapping (oncomapa) in pets
22/09/2025
Index
Introduction
Oncological risk mapping (Oncomapa) can transform the care provided by pet owners and veterinarians regarding the health of dogs and cats.
By identifying genetic predispositions for different types of cancer, this tool enables the adoption of preventive measures that can delay the disease. Furthermore, it allows for the use of personalized clinical monitoring strategies.
In a world where pets are increasingly considered family members, investing in advanced diagnostic solutions is essential to ensure quality of life and longevity . Learn more about this technology and see its benefits!
The importance of genetic mapping in pets.
Oncological risk mapping (Oncomapa) goes beyond simply detecting genetic alterations. It represents a preventative tool capable of changing the course of an animal's life, as it allows for the identification of risks even before any symptoms appear.
This is especially relevant because many oncological diseases in pets are only diagnosed in advanced stages, when treatment options are more limited.
By integrating cancer risk mapping (Oncomapa) into clinical monitoring, the veterinarian can indicate what is necessary for the pet's well-being, such as complementary exams, regular check-ups, and even lifestyle adjustments.
Oncomapa's relationship with preventive genetic testing.
Like cancer risk mapping (Oncomapa), genetic testing in animals serves interests that go beyond health issues.
Many pet owners seek to understand the breed composition of their dogs and cats to understand specific behaviors and needs. However, the great advantage lies in the possibility of identifying genetic predispositions to serious diseases.
By combining prevention and genetic information, the pet owner gains a more holistic view of their pet, uniting curiosity and responsibility.
Practical benefits for pet owners and veterinarians.
Oncological risk mapping (Oncomapa) offers clear benefits for those who live with pets. For pet owners, it represents peace of mind knowing they are investing in prevention and personalized care. For veterinarians, it is a diagnostic support tool that enhances their ability to guide treatments and monitoring strategies.
Based on the results, professionals may recommend periodic check-ups, imaging tests, or even dietary changes.
Impact on quality of life
Another benefit of oncological risk mapping (Oncomapa) is its direct impact on the quality of life of pets. By identifying predispositions, owners and veterinarians can act before symptoms appear, increasing the chances of successful treatment.
Furthermore, the predictability provided by the test helps reduce future costs associated with complex treatments. Therefore, investing in this test is a way to combine care, savings, and love for animals.
Petgenoma as a reference in Latin America
petgenoma has established itself as a leading provider of genetic testing for dogs and cats in Latin America. With its own laboratory and a highly qualified scientific team specializing in canine genetics and bioinformatics, the company combines technical expertise with a passion for animals.
Oncological risk mapping (Oncomapa) is just one of the solutions offered, but it represents an important milestone in the prevention of serious diseases. By bringing cutting-edge technology, unprecedented in Latin America, precision, and customer support, petgenoma reinforces its commitment to transforming the relationship between pet owners, veterinarians, and pets.
Meet petgenoma: your partner in genetic testing for pets.
Want to take the best possible care of your pet's health? Then petgenoma is the ideal company for that.
Specializing in pet genetics, petgenoma offers highly accurate tests, focusing on preventative medicine, breed identification, and disease predisposition. With our own laboratory and database in Brazil, we guarantee results with 98% accuracy using Illumina technology.
The process is simple: the pet owner collects the sample at home using a buccal swab, sends it to the lab, and receives the results within 15 business days, with full support throughout all stages.
The company offers different kits, geared towards dogs and cats. With the Breed Identification Kit , you have access to the pet's origin, confirmation of parentage, consanguinity, and physical characteristics.
Want more? Then you might be interested in the Premium Kit , which offers breed assessment, but also analyzes more than 300 diseases. There's also the Premium Clinical Kit , which provides all of that, plus analyzes the pet's oncological and obesity risks.
Therefore, if you want to get to know your pet deeply and ensure a healthier life for them, count on petgenoma. Check out our products , make your purchase on the website, or send a message on WhatsApp . Discover how genetics can transform your relationship with your furry friend!
Do you own a veterinary clinic, pet shop, or breeding facility and are interested in our product? Then learn more about our partnerships and stand out in the animal care field!
Oncological risk mapping (Oncomapa): conclusion
Oncological risk mapping (Oncomapa) is an advancement in preventive veterinary medicine. Among other things, it allows for the identification of genetic predispositions, guides personalized care, and increases the chances of early diagnosis.
Therefore, for pet owners, this test represents an opportunity to offer their pets a better quality of life and longevity. After all, it expresses the sum of responsibility, affection, and information.
Essay
Petgenoma
